Devices and technology: Continuous glucose monitoring

Giving people with type 2 diabetes “wear-and-forget” masked flash glucose monitoring to allow their healthcare providers access to detailed glucose profiles is feasible in primary care, but it is not clear how beneficial this is, show the results of the GP-OSMOTIC trial.

Findings from a UK feasibility study suggest that continuous glucose monitoring is an acceptable approach for older people with diabetes and memory problems, but devices with automated transfer of glucose readings may be needed to improve completeness of data capture.

People with type 1 diabetes rarely achieve the current targets for blood glucose control, with nocturnal hypoglycemia remaining a particular concern, shows an analysis of the DCCT/EDIC cohort.

Analysis of the GOLD study suggests that at least three-quarters of people with type 1 diabetes using multiple daily injections benefit from continuous glucose monitoring.

The COMISAIR-2 researchers have reported that use of continuous glucose monitoring by people with type 1 diabetes remains high over 3 years, resulting in continued glycemic benefits.

Switching to a predictive low-glucose suspend insulin delivery system significantly reduces hypoglycemia risk in people with diabetes in clinical practice, research shows.

Continuous glucose monitoring offers many benefits to the families of young children with type 1 diabetes but also a number of challenges that cannot always be overcome, show results of a qualitative analysis conducted in the USA.

Glycated hemoglobin levels correlate strongly with continuous glucose monitoring-measured average blood glucose and hyperglycemia, but poorly with hypoglycemia, say researchers.

A statement from an ATTD consensus group has streamlined previously agreed continuous glucose monitoring metrics and set out time in range targets.

Most hypoglycemia outcomes measured by real-time continuous glucose monitoring can be used to predict future severe hypoglycemia in people with type 1 diabetes, with similar levels of accuracy, study findings indicate.

Exposure to hypoglycemia deceases significantly with increasing levels of insulin suspension automation in people with type 1 diabetes, real‐world study data show.

People with type 1 diabetes have high-priority concerns that go beyond glucose control, including complex and mentally taxing treatment and weight gain, report researchers.

Even with newer devices, continuous glucose monitoring underestimates the fall in glucose levels during exercise, with the drop lagging significantly behind that measured by self-monitoring of blood glucose, research shows.

People with type 1 diabetes at high hypoglycemia risk using insulin pumps have fewer hypoglycemic events if the pump is linked to a continuous glucose monitor and has a suspend-before-low feature, SMILE study data show.

The frequency at which people with type 1 diabetes experience hypoglycemia decreases during the first 30 days after they switch to a continuous glucose monitor that incorporates a predictive low-glucose alert, research shows.

Baseline data from the WISDM trial show that older adults with type 1 diabetes who have impaired awareness of hypoglycemia symptoms can spend over half an hour per day with extremely low blood glucose levels.

Using continuous glucose monitoring for all women with type 1 diabetes during pregnancy could save the UK National Health Service over 9 million pounds per year, report the CONCEPTT investigators.

Giving children continuous glucose monitoring from the point of diabetes diagnosis gives their caregivers greater confidence to manage hypoglycemia and reduces their diabetes-related distress, shows a randomized trial.

Continuous glucose monitoring has a less impressive effect on patient-reported outcomes than on glycemic control among patients with type 1 diabetes, reveal the HypoDE investigators.

Home use of day and night hybrid closed-loop insulin delivery using the Cambridge model predictive control algorithm is feasible in children aged 1–7 years with type 1 diabetes, researchers report.